Skip to main content
logo
Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.650
-0.110 (-6.25%)
Nov 18, 2025, 4:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202014 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2014 - 2019
Novel Therapeutics
160.18M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
-17.70%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202014 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2014 - 2019
United States
160.18M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-17.70%
Log In
Log In
Log In
Log In
Upgrade